Back to top
more

LifeMD (LFMD)

(Real Time Quote from BATS)

$11.68 USD

11.68
193,620

-0.27 (-2.26%)

Updated Apr 29, 2024 11:22 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 14.29% and 10.36%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Lilly (LLY) Starts Website to Help Access Tirzepatide Drugs

by Zacks Equity Research

Eli Lilly's (LLY) digital pharmacy is expected to provide patients easy access to its FDA-approved tirzepatide medicines, Mounjaro and Zepbound.

Doximity (DOCS) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Doximity (DOCS) delivered earnings and revenue surprises of 26.67% and 1.40%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 88.89% and 2.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Life Time Group Holdings, Inc. (LTH) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Life Time Group Holdings, Inc. (LTH) delivered earnings and revenue surprises of 22.22% and 0.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Charles River Laboratories (CRL) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Charles River (CRL) delivered earnings and revenue surprises of 4.78% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeMD, Inc. (LFMD) Upgraded to Buy: Here's Why

by Zacks Equity Research

LifeMD, Inc. (LFMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LifeMD, Inc. (LFMD) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 3.85% and 6.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OpGen, Inc. (OPGN) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

OpGen, Inc. (OPGN) delivered earnings and revenue surprises of 6.25% and 55.24%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeMD, Inc. (LFMD) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 25.64% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Surpasses Q4 Earnings Estimates

by Zacks Equity Research

Progyny (PGNY) delivered earnings and revenue surprises of 275% and 6.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

NovoCure (NVCR) delivered earnings and revenue surprises of -150% and 1.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook Highlights: AMN Healthcare Services, Apollo Medical Holdings, Inc. and LifeMD, Inc

by Zacks Equity Research

AMN Healthcare Services, Apollo Medical Holdings, Inc. and LifeMD, Inc are highlighted in this Industry Outlook article.

Zacks Industry Outlook Highlights: AMN Healthcare Services, Apollo Medical Holdings, Inc and LifeMD, Inc

by Zacks Equity Research

AMN Healthcare Services, Apollo Medical Holdings, Inc and LifeMD, Inc are highlighted in this industry outlook article.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy Despite Near-Term Industry Woes

by Urmimala Biswas

The Zacks Medical - Services industry is growing on digital healthcare adoption. AMN, AMEH and LFMD are set to gain the most. However, falling healthcare spending may disrupt the trend.

LifeMD, Inc. (LFMD) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 26.53% and 1.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for August 26th

by Zacks Equity Research

FSLY, GNSS, LFMD, NUAN, and QUOT have been added to the Zacks Rank #5 (Strong Sell) List on August 26, 2021

LifeMD, Inc. (LFMD) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of -13.33% and 3.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: LifeMD, Inc. (LFMD) Q2 Earnings Expected to Decline

by Zacks Equity Research

LifeMD, Inc. (LFMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LifeMD, Inc. (LFMD) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 13.64% and -0.12%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Do Options Traders Know Something About LifeMD (LFMD) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to LifeMD (LFMD) stock based on the movements in the options market lately.

Analysts Estimate LifeMD, Inc. (LFMD) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

LifeMD, Inc. (LFMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Do Options Traders Know Something About LifeMD (LFMD) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to LifeMD (LFMD) stock based on the movements in the options market lately.